Evidence map›Paper›PMID 29258242›Full record

ArticleDiseases (Basel, Switzerland)2017

Successful Treatment of Pulmonary and Cerebral Toxoplasmosis Associated with Pneumocystis Pneumonia in an HIV Patient.

Marie-Françoise Rey, Charles Mary, Diane Sanguinetti, Stéphane Ranque, Christophe Bartoli, Coralie L'Ollivier

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diseases (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marie-Françoise ReyDepartment of Interregional Secure Hospital, AP-HM, University Hospital, 13915 Marseille CEDEX, France. Marie-francoise.REY@ap-hm.fr.
Charles MaryUniversité Aix Marseille, CNRS 7278, IRD 198, Inserm 1095, AP-HM, URMITE, IHU Méditerranée Infection, 13915 Marseille CEDEX, France. charles.mary@ap-hm.fr.
Diane SanguinettiUniversité Aix Marseille, CNRS 7278, IRD 198, Inserm 1095, AP-HM, URMITE, IHU Méditerranée Infection, 13915 Marseille CEDEX, France. diane.sanguinettimorelli@gmail.com.ORCID 0000-0002-4607-2160
Stéphane RanqueUniversité Aix Marseille, CNRS 7278, IRD 198, Inserm 1095, AP-HM, URMITE, IHU Méditerranée Infection, 13915 Marseille CEDEX, France. stephane.ranque@ap-hm.fr.ORCID 0000-0003-3293-5276
Christophe BartoliDepartment of Interregional Secure Hospital, AP-HM, University Hospital, 13915 Marseille CEDEX, France. christophe.bartoli@ap-hm.fr.
Coralie L'OllivierUniversité Aix Marseille, CNRS 7278, IRD 198, Inserm 1095, AP-HM, URMITE, IHU Méditerranée Infection, 13915 Marseille CEDEX, France. coralie.lollivier@ap-hm.fr.ORCID 0000-0002-1086-3745
Centre National de la Recherche Scientifique · FRAssistance Publique Hôpitaux de Marseille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In both the post and pre combination antiretroviral therapy (cART) era,

Indexed as

cerebralPneumocystis jiroveciipneumoniaToxoplasma gondiitrimethoprim/sulfamethoxaxole

Identifiers

PMID29258242
PMCPMC5750546
OpenAlexW2776437459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.